| Determinants of knowledge of HIV status in South Africa: results from a population-based HIV survey K Peltzer, G Matseke, T Mzolo, M Majaja BMC public health 9, 1-11, 2009 | 231 | 2009 |
| Age at sexual debut: a determinant of multiple partnership among South African youth K Zuma, G Setswe, T Ketye, T Mzolo, T Rehle, N Mbelle African journal of reproductive health 14 (2), 47-54, 2010 | 134 | 2010 |
| South African national HIV prevalence, incidence, behaviour and communication survey, 2008: the health of our children O Shisana, LC Simbayi, T Rehle, NP Zungu, K Zuma, N Ngogo, S Jooste, ... HSRC Press, 2010 | 62 | 2010 |
| Determinants of age at sexual debut and associated risks among South African youths K Zuma, T Mzolo, E Makonko African Journal of AIDS Research 10 (3), 189-194, 2011 | 31 | 2011 |
| A comparison of statistical methods for combining relative bioactivities from parallel line bioassays T Mzolo, M Hendriks, E van den Heuvel Pharmaceutical statistics 12 (6), 375-384, 2013 | 10 | 2013 |
| MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: results from a phase IIIb, multicenter, open label study in adolescents and adults M Tipton, W Daly, S Senders, SL Block, M Lattanzi, T Mzolo, S Barbi, ... Vaccine 37 (42), 6171-6179, 2019 | 9 | 2019 |
| Sexual behaviour, HIV status, and HIV risk among older South Africans K Peltzer, N Phaswana-Mafuya, T Mzolo, C Tabane, K Zuma Studies on Ethno-Medicine 4 (3), 163-172, 2010 | 8 | 2010 |
| Dual protection, contraceptive use, HIV status and risk among a national sample of South African women K Peltzer, T Mzolo, N Mbelle, L Tsoai, N Lewa, N Ncitakalo Gender and Behaviour 8 (1), 2833-2845, 2010 | 6 | 2010 |
| Immunogenicity of a quadrivalent human papillomavirus vaccine when co-administered with tetanus-reduced diphtheria-acellular pertussis and quadrivalent meningococcal conjugate … Y Miao, T Mzolo, M Pellegrini Infectious Diseases and Therapy 8, 335-341, 2019 | 5 | 2019 |
| Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study … J Díez-Domingo, JC Tinoco, A Poder, EC Dinleyici, H Nell, ... Human vaccines & immunotherapeutics 18 (1), 1981085, 2022 | 4 | 2022 |
| Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster … MM Giuliani, A Biolchi, P Keshavan, M Moriondo, S Tomei, L Santini, ... Human Vaccines & Immunotherapeutics 17 (5), 1442-1449, 2021 | 3 | 2021 |
| Statistical methods for the analysis of bioassay data TV Mzolo | 3 | 2016 |
| Statistical Process Control Methods for Monitoring In-house Reference Standards T Mzolo, G Goris, E Talens, AD Bucchianico, E Heuvel Statistics in Biopharmaceutical Research, 55-65, 2015 | 3 | 2015 |
| Estimating risk determinants of HIV and TB in South Africa. T Mzolo | 2 | 2009 |
| Bayesian approach in estimating risk determinants of infectious diseases T Mzolo | 2 | 2008 |
| Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis P Vir Singh, P Tiberi, GF Di Domenico, V Romolini, T Mzolo, M Costantini, ... Drug Safety 46 (1), 99-108, 2023 | 1 | 2023 |
| Equivalence testing for similarity in bioassays using bioequivalence criteria on the relative bioactivity C Baljé‐Volkers, T Mzolo, E Talens, P IJzerman‐Boon, E Van den Heuvel Pharmaceutical Statistics 17 (1), 12-24, 2018 | 1 | 2018 |
| Bayesian vs Frequentist Approaches in Estimating the Risk Determinants of Infectious Diseases T Mzolo, H Mwambi, K Zuma | 1 | 2009 |
| Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis. P Tiberi, GF Di Domenico, V Romolini, T Mzolo, M Costantini, T Akhund, ... Drug Safety, 2022 | | 2022 |
| 2456. Immunogenicity and Safety of a MenACWY-CRM Booster Dose 4–6 Years After Primary Quadrivalent Meningococcal Conjugate Vaccination in Healthy US Adolescents and Adults M Tipton, W Daly, S Senders, SL Block, P Keshavan, T Mzolo, ... Open Forum Infectious Diseases 5 (Suppl 1), S735, 2018 | | 2018 |
Karl PeltzerAsia UniversityVerified email at asia.edu.tw
Karl PeltzerAsia UniversityVerified email at asia.edu.tw